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Background: Breast cancer has been poorly studied in women with intellectual disability (ID), which makes
designing a policy for screening the nearly 70 million women with ID in the world difficult. As no data is available
in the literature, we evaluated breast cancer at diagnosis in women with ID.
Methods: Women with ID were searched retrospectively among all women treated for invasive breast cancer in a
single hospital over 18 years. Age at diagnosis was compared among the whole group of women. Tumor size,
lymph node involvement, SBR grade, TNM classification, and AJCC stage were compared to controls matched for
age and period of diagnosis using conditional logistic regression.
Results: Among 484 women with invasive breast cancer, 11 had ID. The mean age at diagnosis was 55.6 years in
women with ID and 62.4 years in the other women. The mean tumor size in women with ID was 3.53 cm,
compared to 1.80 cm in 44 random controls from among the 473 women without ID. Lymph node involvement
was observed in 9 of the 11 women with ID compared to 12 of the controls (OR = 11.53, p = 0.002), and metastases
were found in 3 of the 11 women with ID compared to 1 of the 44 controls (OR = 12.00, p = 0.031). The AJCC stage
was higher in women with ID compared to controls (OR = 3.19, p = 0.010).
Conclusions: Women with ID presented at an earlier age with tumors of a higher AJCC stage than controls despite
no significant differences in tumor grade and histological type. Thus, delayed diagnosis may be responsible for the
differences between disabled and non-disabled women.
Keywords: Breast cancer, Cancer screening, Cancer stage, Diagnosis delay, Intellectual disabilityBackground
The life expectancy of people with intellectual disability
(ID) has increased, but they are now exposed to greater
cancer risk [1]. The global frequency of all cancers has
been estimated to be similar in people with ID and the
general population [2,3]. Despite differences in cancer
distribution according to various organs in persons with
ID, breast cancer incidence appears to be similar in
women with ID and in non-disabled women [2,4,5]. A
lack of research exists in the field of breast cancer in* Correspondence: danielsatge@orange.fr
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reproduction in any medium, provided the orwomen with ID [6], and very little is known about its
clinical presentation, particularly regarding age and
tumor stage at diagnosis. However, this information is
important for adapted breast cancer monitoring and effi-
cient breast cancer treatment in these women. We
present a series of 11 consecutive women with ID
treated for invasive breast carcinoma followed in a hos-
pital. The differences we observed from the general
population deserve attention, as this question regards
nearly 70 million women with ID worldwide.
The frequency of breast cancer in women with ID is not
well known. An epidemiological study in Finland reported
a similar incidence in the general population [2]. Another
epidemiological study in Australia reported a lower inci-
dence of 0.69. However, the authors discussed thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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among women with ID is related to an under-utilization of
screening services [5]. An institutional study reported that
breast cancer (13 of 51 cases) is the most frequent cancer
in women [7]. A Dutch institutional survey reported eight
malignancies in women with moderate and severe ID,
among which four were breast cancer, suggesting a fre-
quency of breast cancer at least equal to that of the general
population [4]. Some conditions, such as Down syndrome
[8] and fragile X syndrome [9], occur at a lower frequency
in breast cancer patients compared to the general popula-
tion, whereas other subgroups, such as patients with cere-
bral palsy [10] or Cowden syndrome [11], occur at a higher
frequency among breast cancer patients. For the whole
group, including patients with genetic and non-genetic con-
ditions, nulliparity [12], being overweight, and a lack of ex-
ercise [6] are factors that increase breast cancer risk.
Although breast cancer is probably the most frequent
malignant neoplasm in women with ID, little data is
available to support this. The few epidemiological studies
[2,3] and institutional reports [4,7] do not provide de-
tailed clinical information. In addition, the few case re-
ports [13-16] do not give a precise idea of the disease for
the whole group. Our series of 11 consecutive patients is
the first clinically detailed series of women with ID with
breast cancer. Our observations of histology, tumor
grade, age, tumor size, and disease stage at diagnosis are




Ethical approval, as well as permission to create, complete,
and access the comprehensive database used in this study,
was provided by the Ethics Group of Tulle hospital.
Women with ID were searched retrospectively among all
women treated for invasive breast cancer (excluding in situ
carcinoma) during the 18-year period from 1989 January 1
to 2006 December 31. These dates were chosen because
the same pathology team received all breast biopsies and
surgical resections during the period. ID is defined as a
limitation of intellectual functioning (IQ < 70) associated
with a limitation of adaptive behavior first observed before
the age of 20 years [13]. This definition excludes patients
with late occurring intellectual impairment, such as
Alzheimer’s disease. Various psychiatric conditions, such as
schizophrenia, were excluded if they were not associated
with an ID appearing before the age of 20 years. On the
basis of a list of 484 consecutive women with invasive
breast cancer, the first step was to ask members of the
Gynecology-Obstetrics team of Tulle hospital, particularly
physicians, nursing professionals, and secretaries, to recall
any patients with intellectual impairment. Hospital records
were examined to assess the deficiency and age at onset. Inaddition, one of us (DS) interviewed the general practi-
tioner (GP) of each of these women directly, searching for
intellectual impairment. Identifying ID was easy for women
living in an institution for persons with ID and for women
followed by the social service involved with ID. For other
women, the advice of a psychologist and/or psychiatrist was
sought. In a complementary approach, all institutions in
the hospital area that shelter patients with ID were con-
tacted by phone, and the psychosocial team, nursing team,
and attached GP were interviewed to search for women
who developed breast cancer in the institution during the
study period. The aim was to determine whether women
with ID and breast cancer in the area were treated some-
where other than Tulle hospital. This last search was also
to ensure we did not miss patients forgotten by both the
hospital team and GPs.
Patient characteristics
For each patient, we interviewed hospital professionals,
GPs, and institution teams, and searched in hospital re-
cords and institution records for data on mental state
and physical health. Women with ID were classified
into three groups: mild ID (IQ 69–50), moderate ID (IQ
49–35), or severe and deep ID (IQ < 34). Data on family
diseases, particularly in regards to mental state and
cancer, were obtained by interviewing family members
when available, and institutional professionals for pa-
tients with no known familial link. Regarding cancer, for
each woman with ID and breast cancer we noted the age
at diagnosis, whether they lived in an institution, the
community, or with family, and the mode of tumor dis-
covery. We also noted tumor side, possible multifocality,
and the greatest tumor diameter estimated with a micro-
scope. In the case of plurifocal cancer, the diameter was
measured for the largest foci. Only the invasive compo-
nent was measured when in situ carcinoma was associ-
ated. The histological type, the Scarff, Bloom, and
Richardson (SBR) grade, lymph node involvement, blood
metastasis before treatment, and tumor stage were re-
corded using the TNM classification and AJCC/UICC
staging system [17]. Other information regarding treat-
ment and evolution are beyond the scope of this article,
which deals with the clinical presentation.
Comparison with non-disabled women and
statistical analysis
The age at diagnosis between women with ID and all
non-disabled women in the list of women treated for
breast cancer at Tulle hospital was compared by unilat-
eral Student t test after assessing normality using a
Lilliefors-Kolmogorov-Smirnov test and variance homo-
geneity using the Bartlett test. Tumor size (greatest
diameter), SBR grade, lymph node metastasis, blood me-
tastasis, and stage at diagnosis were compared after
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were randomly selected after matching for age (in
groups of 5 years, e.g., 40–45, 46–50, and 51–55; using
the closest year when no case was available within this
range) and for the year of diagnosis, or the 2 or 3 years
around the year of diagnosis. To maximize the statistical
power, four controls were matched with each case.
Matching addresses issues of confounding in the study.
Without matching, when a sample size is small, the ana-
lysis can result in many strata with very sparse data. Lit-
tle improvement was made in precision by increasing
the ratio of controls to cases beyond four [18].
Due to this matching, all analyses were carried out using
conditional logistic regression. Statistical tests were consi-
dered significant with a 5% alpha risk. Statistical analyses
were carried out using the R statistical software [19].
Results
Patient characteristics
Among 484 women with breast cancer, three malignant
mesenchymal tumors and one lymphoma were excluded,
leaving 480 women with breast carcinoma, corresponding
to 379 cases of invasive ductal carcinoma, 73 invasive lobu-
lar carcinoma, 12 mucinous carcinoma, 10 medullary car-
cinoma, 3 papillary carcinoma, and one each of fusocellular,
spindle cell, and neuroendocrine carcinoma. Ten women
with ID were treated for invasive ductal carcinoma and one
for mucinous carcinoma. Biological behavior, particularly
aggressiveness, varies according to histological type; thus,
we limited the comparison of women with ID to non-
disabled women with invasive ductal carcinoma.
The etiology of ID was known in three women (Table 1).
No genetic condition was identified in the group, including
Down syndrome. Five women had mild ID: two with mod-
erate ID and four with severe or deep ID. Four patients
were living in an institution. Ten patients were born in the
department of Correze, and one arrived from another
region of France. Two patients were married. We did not
observe that women with ID who developed breast cancer
were from families with particular socioeconomic
characteristics.Table 1 Patients characteristics in a series of 11 women with
ID Level 4 mild ID, 3 moderate ID, 4 severe ID
4 patients lived in institution, 7 in their family.
ID Etiology No genetic condition identified, but 1 case of low I
1 neonatal anoxia, 1 encephalitis at 6 months, 1 stro
Comorbidities 2 blindness, 2 urinary and fecal incontinence, 2 epil
Personal and familial
cancer
1 patient with sister having breast cancer, 1 patient
one patient’s father and sister having cancer.
One patient was treated for a facial basal cell carcin
ID=Intellectual disability.Breast cancer was diagnosed at a mean age of 55.64 years
for the 11 women with ID, and 5 out of 11 tumors were
found before the age of 50 years. Although no particular ac-
tion was conducted regarding cancer in women with ID
during the study period, tumors were diagnosed at an older
age during the first 9 years (mean 65 years) compared to
the last 9 years (mean 49 years). Two of the patients discov-
ered the tumor themselves (patients 4 and 7), two tumors
were discovered by the GP during a systematic clinical
examination (patients 2 and 5). Three tumors were discov-
ered by a family member or a caregiver (patients 3, 6,
and 8). Two tumors were found at mammography, one
during a screening campaign (patient 9) and the other
requested from the GP by the patient (patient 10). In two
patients, painful symptomatic bone metastases and pleural
metastases revealed the tumor (patients 1 and 11). The
tumor characteristics are reported in Table 2. Histological
examination of tumors in women with ID did not show
particular microscopic features. In Tulle area institutions,
we did not find other patients with breast cancer who were
treated in another hospital during the study period.
Comparison with non-disabled women
The mean age at diagnosis for the 11 women with ID
was 55.64 years (standard deviation [SD] 11.94 years).
For all 473 cancers in non-disabled women the mean
age at diagnosis was 62.35 years (SD 14.24). The mean
age of women with ID was significantly lower than that
of the 473 controls (p = 0.047, unilateral Student t test).
The 11 women with ID were then matched to controls
based on age (5-year band), year of diagnosis, and histo-
logical type, and the following analyses carried out using
conditional logistic regression. The mean tumor size, as
evaluated by the mean greatest diameter, was 3.53 cm
(range 1.5 – 8 cm, SD 1.87) in the 11 women with ID
and 1.80 cm (range 0.3 - 4.5, SD 0.97) in the group of 44
controls. Women with ID exhibited a higher risk of hav-
ing a greater tumor size than controls (odds ratio [OR]
2.66 [1.26-5.65], p = 0.010 for an increase of 1 cm).
Lymph node metastases were found in 9 of the 11
women with ID and 12 of the 44 controls. The OR of aintellectual disability and breast carcinoma
Q in the family;
ke at 6 months.
epsy, 2 schizophrenia, 1 mental depression, 1 alcoholism.
’s mother with uterine cancer and grand-mother with thyroid cancer,
oma
Table 2 Breast cancer age and stage at diagnosis in 11 women with intellectual disability
Date of diagnosis 1993-1999 = 5 2000–2006 = 6
Age at diagnosis < 50y = 5 50-59y = 2 ≥ 60y = 4
Tumor size ≤ 1.9 cm = 2 2–4.9 cm = 6 ≥ 5 cm = 3
SBR grade I = 0 II = 5 III = 6
Lymph node involvement 9/11 1 to 13 nodes involved
Metastases 3 bones, one associated with pleura, one associated with liver
TNM classification T1 N0 M0 = 1 T2 N0 M0 = 1 T2 N1 M0 = 6
T2 N1 M1 = 1 T3 N1 M1 = 1 T4 N1 M1 = 1
y=years.
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55.48] (p = 0.002) compared to controls. Visceral metas-
tases at diagnosis were observed in 3 of the 11 women
with ID and 1 of the 44 controls (OR 12.00 [1.25-115.4],
p = 0.031). Women with ID exhibited a SBR grade of 2
(n = 5) or 3 (n = 6), whereas controls had grades of 1
(n = 6), 2 (n = 18), or 3 (n = 20). When using the grade
as a discrete variable, the OR was 1.69 [0.57-5.00]
(p = 0.340). The AJCC stage at diagnosis was 1 for 1
woman with ID and 24 controls, 2 for 7 women with ID
and 18 controls, 3 for 1 control (and no women with
ID), and 4 for 3 women with ID and 1 control (OR using
AJCC 1 as the reference category 3.19 [1.32-7.73],
p = 0.010, Table 3).
Discussion
In our series, 11 women with ID accounted for 2.23% of
all women treated for invasive breast cancer in the hos-
pital during the 18-year period. As the frequency of ID
is estimated to be nearly 2.5% of the population in
Western countries [13], this observation is in agreement
with the idea that breast cancer is as frequent in women
with ID as in women of the general population [2,4,5,7].
Tumor size and stage
A previous study reported that disabled women tend to
be diagnosed with breast cancer at later stages [20].
However, both women with physical disabilities and
women with ID were included and, as no information
on specific medical conditions was provided, evaluating
the extent to which this applies to women with ID inTable 3 Regression analysis of breast cancer in 11 women
with ID compared to controls
OR 95% CI p-value
Tumor size (mm) 2.66 [1.26-5.65] 0.010
Lymph node metastasis 11.53 [2.40-55.48] 0.002
Visceral metastases 12.00 [1.25-115.4] 0.031
SBR grade (reference grade 1) 1.69 [0.57-5.00] 0.340
AJCC stage (reference AJCC 1) 3.19 [1.32-7.73] 0.010particular is not possible. In our series, women with ID
had tumors with greater volume at diagnosis compared
to controls, lymph node involvement was more than 11-
times more frequent, and blood metastases were 12-
times more frequent. Women with ID were more likely
to have a higher AJCC stage. The OR was estimated to
be 3.2 compared to AJCC 1; thus, women with ID had
3.2-times higher risk of AJCC 2 compared to non–dis-
abled patients. Similarly, women with ID had a 10.2-
times higher risk of AJCC 3 (with respect to AJCC 1).
Aggressive breast cancer with a fast growth rate could
explain larger tumors and more advanced stage at diag-
nosis in women with ID compared to non-disabled
women. However, because histological type and SBR
grade did not significantly differ between the two
groups, this possibility is not likely. On the other hand,
prolonged delay in the diagnosis of breast cancer has
been associated with increased tumor size, increased
nodal involvement, and metastasis leading to a more ad-
vanced tumor stage [21,22].
Age at diagnosis
In this series, breast cancer was discovered at the mean age
of 55.64 years in women with ID and 62.35 years in the
whole group of 473 non-disabled women with breast can-
cer. The younger age at diagnosis is an unexpected finding
of the study. In some genetic conditions associated with ID
and increased cancer risk, such as Cowden syndrome,
type 1 neurofibromatosis, and Saethre-Chotzen syndrome
[11,23,24], breast cancer occurs earlier than in the general
population. However, no particular genetic condition was
identified in this series. From a practical point of view, par-
ticularly for monitoring, whether breast cancer occurs earl-
ier in women with ID needs to be established; if women
with ID are diagnosed at an earlier age, different screening
guidelines may be needed, such as earlier breast cancer
screening for women with ID. In France, the national breast
cancer screening policy targets women between 50 and
74 years of age. Applying this policy to the women with ID
in our series would have missed nearly half of the tumors
because 5 of 11 patients were diagnosed before 50 years of
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woman through breast cancer screening, which began in
2001 in the Tulle area. If an earlier age is confirmed by lar-
ger samples, research would be needed to understand why
women with ID develop breast cancer earlier than non-
disabled women.
Delay in diagnosis
The optimal care of breast cancer relies on early diagnosis.
For breast cancer, the policy is based on good general med-
ical follow-up and breast cancer screening in countries
where it has been established. Early detection of cancer in
individuals with ID is often difficult [25] due to difficulties
performing the clinical examination, communication prob-
lems, and under-recognized pain by caregivers [26]. In
addition, the knowledge regarding breast cancer in women
with ID is limited, including signs and symptoms of breast
cancer and breast cancer awareness [27,28]. Women with
ID do not practice breast self-examination similar to
women in the general population and may not fully under-
stand the importance of this surveillance [6,29]. A need ex-
ists to train institution staff and women with ID family
members in order to enhance our knowledge of breast can-
cer risk and surveillance [6,30]. The literature on breast
cancer screening in women with ID shows that much re-
mains to be done for better monitoring [3,31-34]. Studies
in various countries have shown that indications for mam-
mography and uptake of mammography screening are usu-
ally lower, and sometimes much lower, in women with ID
[31]. Efforts should be made to include more women with
ID in screening programs. Previous literature under-
evaluated cancer frequency in people with ID [1], and given
the lack of clear recent documentation, GPs, families, and
caregivers may be less aware of the true cancer risk in
women with ID. All of these obstacles and difficulties could
explain the delay in breast cancer diagnosis in women with
ID. Our study suggests that more attention should be given
to an early diagnosis of breast cancer in women with ID.
Our study has some weaknesses: the study is retro-
spective, few patients were studied (resulting in large
confidence intervals, no multivariate analysis was pos-
sible), and we did not include population-based data. On
the other hand, the strengths of the study are that all pa-
tients were followed by the same gynecologic team and
tumors evaluated by the same pathology team. The
source was the same for patients and controls. In
addition, due to the small size of the sample, each pa-
tient characteristic could be closely examined. A larger
study of breast cancer characteristics at diagnosis is now
warranted.
Conclusion
This first study of breast cancer characteristics at diagnosis
in women with ID agrees with recent epidemiological datashowing that these cancers are as frequent in women in the
general population. We also observed that cancers were
found at a more advanced stage and younger age in women
with ID than in the general population, despite no signifi-
cant differences in histological type and tumor grade. These
findings warrant a larger study in order to provide a basis
for the best care from prevention to long-term treatment of
women with ID with breast neoplasia. These findings
should encourage work to assess breast cancer risk in
women with ID, to search for particular risk factors accord-
ing to ID level, ID etiology, social level, and screening at-
tendance and to evaluate age at onset for good monitoring.
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